Gonadotrophin-inhibiting factor in secondary amenorrhea.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000652:urine*; D000856:Anorexia Nervosa / Q000150:complications; D001681:Biological Assay; D002624:Chemistry, Clinical; D003863:Depression / Q000150:complications; D004967:Estrogens / Q000652:urine; D005260:Female; D006065:Gonadotropins, Pituitary / Q000037:antagonists & inhibitors*; D006801:Humans; D007046:Hysteria / Q000150:complications; D008607:Intellectual Disability / Q000150:complications; D007986:Luteinizing Hormone / Q000037:antagonists & inhibitors*; D008875:Middle Aged; D011276:Pregnanediol / Q000652:urine; D011618:Psychotic Disorders / Q000150:complications; D012559:Schizophrenia / Q000150:complications
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D004967:Estrogens; D006065:Gonadotropins, Pituitary; D007986:Luteinizing Hormone; D011276:Pregnanediol